Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Aug 10.
Published in final edited form as: J Inorg Biochem. 2008 Sep 5;103(1):10–19. doi: 10.1016/j.jinorgbio.2008.08.012

1H NMR study of the effect of variable ligand on heme oxygenase electronic and molecular structure

Li-Hua Ma a, Yangzhong Liu a,1, Xuhong Zhang b, Tadashi Yoshida b, Gerd N La Mar a,*
PMCID: PMC2724318  NIHMSID: NIHMS96654  PMID: 18976815

Abstract

Heme oxygenase carries out stereospecific catabolism of protohemin to yield iron, CO and biliverdin. Instability of the physiological oxy complex has necessitated the use of model ligands, of which cyanide and azide are amenable to solution NMR characterization. Since cyanide and azide are contrasting models for bound oxygen, it is of interest to characterize differences in their molecular and/or electronic structures. We report on detailed 2D NMR comparison of the azide and cyanide substrate complexes of heme oxygenase from Neisseria meningitidis, which reveals significant and widespread differences in chemical shifts between the two complexes. To differentiate molecular from electronic structural changes between the two complexes, the anisotropy and orientation of the paramagnetic susceptibility tensor were determined for the azide complex for comparison with those for the cyanide complex. Comparison of the predicted and observed dipolar shifts reveals that shift differences are strongly dominated by differences in electronic structure and do not provide any evidence for detectable differences in molecular structure or hydrogen bonding except in the immediate vicinity of the distal ligand. The readily cleaved C-terminus interacts with the active site and saturation-transfer allows difficult heme assignments in the high-spin aquo complex.

Keywords: Neisseria meningitidis heme oxygenase, Azide complex, Magnetic anisotropies, Dipolar shifts, H-bonding

1. Introduction

Heme oxygenase [1], HO, a member of a class of non-metal enzymes that utilize hemin as cofactor and substrate to convert it into iron, CO and biliverdin via the intermediates, meso-hydroxyhemin, verdoheme and iron-biliverdin [26]. HOs are widely distributed and have been characterized in detail for mammals, plants, cyanobacteria and some pathogenic bacteria. The current understanding of the structure/function relationships for HOs has been aided significantly by crystallographic and NMR spectroscopic structural characterization of primarily human, hHO [712] and rat HO [1317], and on the HOs from the pathogenic bacteria Neisseria meningitidis, NmHO [1826], Corynebacterium diphtheriae, CdHO [16,17,27,28], and Pseudomonas aeruginosa, PaHO [25,2932]. The diverse HOs exhibit a remarkably conserved fold, in spite of only limited sequence homology, that consists of primarily α-helices where the substrate binds to a conserved His near the enzyme surface. Moreover, each HO possesses several ordered water molecules in the distal pocket that are implicated in the HO mechanism [46,33]. The stereoselectivity of the reaction(only α-meso cleavage in mammalian HOs) is rationalized by steric blocking by the distal helix of three meso positions and steric tilt/orientation of the activated Fe+3–OOH towards the fourth unblocked meso position. The stability of Fe+3–OOH to O–O cleavage to yield inactive ferryl species common to peroxidases and cytochromes P450 has been linked to the novel interaction of the exogenous ligand with primarily ordered water molecules [7,8, 1315,18,19,27,29]. Solution 1H NMR has shown [9,10,20,23,25, 34,35] that HOs possess an extended distal H-bond network that contains some much stronger-than normal H-bonds and that several of the ordered water molecules are imbedded within this H-bond network. The fact that mutagenesis of the same key residue within this network of HOs [3638] with highly homologous distal pocket structures differentially effects product formation, suggest that an improved understanding of the influence of the nature of the exogenous ligand on the H-bond network is desirable.

The only readily NMR-addressable, physiologically relevant HO species are diamagnetic, substrate-free, apo-HO, and the resting-state, high-spin ferric, substrate aquo complex. However, while the information content of the high-spin aquo complex is very rich [21,35,39], strong paramagnetic relaxation severely hampers resonance assignment in the absence of isotope-labeled substrate. Since both the initial ferrous-O2 (with one exception [27]) and activated ferric-hydroperoxy [33] species are generally too unstable to investigate at ambient temperatures, both crystal and solution characterization have been carried out on numerous physiologically non-relevant derivatives which model various aspects of HO species. Thus the ferric cyanide [9,14,21,30,34] or azide [13,25] and ferrous NO [8,19,40] or CO [40] complexes have served as models for the oxy complex, and the ferric hydroxy complex has been proposed [5,31] to mimic the hydroperoxy species. For the purposes of NMR spectroscopy, the low-spin azide and cyanide complexes of ferri-hemoproteins are most readily characterized due to favorable relaxation properties that allow detailed 2D NMR characterization, large magnetic anisotropy that facilitates signal resolution, and relatively simple but robust interpretive bases for the hyperfine shifts in terms of functionally relevant molecular/electronic structural parameters [39].

Our interests here focus on the azide complex of protohemin, PH, bound to NmHO for three main reasons. The first is the anticipated set of favorable circumstances that would allow conveniently attainable substrate resonance assignments in the azido-complex to be extended, via magnetization-transfer [41], to the much more difficult-to-assign high-spin, ferric-aquo complexes [25,26,32,39,42,43]. Second, azide provides an oxy model that contrasts cyanide in several ways. Thus, cyanide, like O2, is diatomic but prefers to bind linear and normal to the heme (while the FeOO bond is bent), and is a much weaker H-bond acceptor than O2. Azide exhibits the bent structure like O2, and its H-bond acceptor strength lies between that of O2 and cyanide. Hence, it is of interest to characterize any differences in molecular structure and/or H-bond strength in the H-bond network between the azide and the previously characterized [20] cyanide complex of NmHO. Third, the structural and functional properties of NmHO are, for the most part, typical of those of the structurally characterized mammalian and other bacterial HOs [25,7,8,13,18,19,27,29,44]. However, a C-terminal tripeptide His207Arg208His209 of NmHO, found “missing” in the crystal structures [18,19] and attributed to disorder, was found ordered in solution for NmHO–PH–CN [20,35] and shown to interact strongly with the substrate pocket. Moreover, this C-terminal Arg208His209 peptide is spontaneously cleaved in solution [20,35], which suggests the possibility that the C-terminus was also cleaved in the crystal. The “loss” of this C-terminal dipeptide by “aging” leads to an increased rate of product biliver-din release [35], implicating the C-terminal tail in modulating NmHO activity. It is of interest to ascertain whether the C-terminus similarly interacts with the active site and cleaves in the azide as found for the cyanide complex [35].

Changes in molecular structure upon ligand binding in diamagnetic enzymes are readily detected in the perturbation of chemical shifts of the 15N and 1H in [1H–15N]-HSQC spectra [45]. However, changes in chemical shifts with ligands in paramagnetic enzymes do not allow the same confident analysis due to the presence of dipolar shifts, δdip, given by [39,4648]

δdip=(24πμ0NA)1[3Δχax(3cos2θ1)R3+2Δχrh(sin2θ×cos2Ω)R3]Γ(α,β,γ), (1)

where Δχax and Δχrh are the axial and rhombic anisotropies of the diagonal paramagnetic susceptibility tensor, χ, R, θ′, Ω′ define the nucleus in an iron-centered, reference coordinate system, x′, y′, z′ (Fig. 1), and Γ(α,β,γ) is the Euler rotation that converts the reference into the magnetic coordinate system, x, y, z, in which χ is diagonal. Since the dipolar shifts are very long-ranged, nuclei up to 25 Å from the iron in low-spin ferrihemoproteins can experience non-negligible δdip whose magnitude can depend on the detailed electronic structure of the iron-center (Δχax, Δχrh, α, β, γ in Eq. (1)), even if the molecular structure (i.e., R′, θ′, Ω′ in Eq. (1)) is strongly conserved. Both the anisotropy and orientation of χ can be determined if a significant portion of the active site residues are assigned and their dipolar shifts quantitated.

Fig. 1.

Fig. 1

Schematic of the protohemin (PH) and the paramagnetically influenced proximal (squares) distal (circles) and equatorial (triangles) residues that are predicted to be, and observed, in contact with the heme or each other. The orientation of the axial His23 imidazole plane is shown as a rectangle. Also shown are the reference x′, y′, z′, and the magnetic coordinate systems, x, y, z. The Euler rotation, Γ(α,β,γ), relates the two coordinate systems, [x, y, z] = Γ(α,β,γ)[x′,y′, z′), where β is the tilt of the major magnetic axis, z, from the heme normal (z′ axis), α is the direction of the tilt of the major magnetic axes as given by the angle between the projection of z′ on the x, y plane and the x′ axis; and κ ~ α + γ is the angle between the projection of the x axis on the x′, y′ plane and the x′ axis.

To date, only the substrate resonances have been assigned for NmHO–PH–N3 [25], although both substrate and residue backbone assignments have been reported for PaHO–PH–N3 [32]. It was noted that the pattern of PH methyl hyperfine shifts in the PaHO azide complex differed from that of the same cyanide complex, and the novel intermediate-spin, S = 3/2 ground state, was proposed [25] to account for this. We report here on the detailed assignments of the active site of NmHO–PH–N3, and determine the magnetic axes which indicate that, although significant differences in chemical shifts are observed between the azide and cyanide complexes, they are consistent with arising primarily from differences in the electronic structure of the chromophore and not in the molecular structure and H-bond strengths. Moreover, the C-terminus interacts with the active site and is cleaved in a manner very similar to that reported for the cyanide and aquo complexes [22,24]. Lastly, we show that the azide complex does provide a ready access to the elusive assignment of the substrate resonances in resting-state HO complexes [21,35,39].

2. Materials and methods

2.1. Sample preparation

The apo-NmHO samples used in this study are the same as described in detail previously [20]. Stoichiometric amounts of protohemin, PH (Fig. 1), dissolved in 0.1 M KOH in 1H2O, were added to apo-NmHO in phosphate buffer (50 mM, pH 7.0). The substrate complex was purified by column chromatography on Sephadex G25, and phosphate-buffered KN3 solution at pH 7.1 was titrated in until >95% conversion to the NmHO–PH–N3 complex was achieved ( [N3] ~50 mM). Samples in 1H2O were converted to 2H2O by column chromatography [49].

2.2. NMR spectroscopy

1H NMR data were collected on Bruker AVANCE 500 and 600 spectrometers operating at 500 and 600 MHz, respectively. Reference spectra were collected in 1H2O and 2H2O over the temperature range 15–35 °C at both a repetition rate of 1 s−1 over 40 ppm spectral width and at 5 s−1 over a 200 ppm spectral width. Steady-state magnetization-transfer [41] (NOE or exchange) difference spectra were generated from spectra with on-resonance, and off-resonance, saturation of the desired signals; to detect exchange with H2O, selective 3:9:19 excitation [50] was used. Chemical shifts are referenced to 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) through the water resonance calibrated at each temperature. Non-selective T1s were determined by the standard inversion-recovery pulse sequence and estimated from the null point. 600 MHz NOESY spectra [51] (mixing time 40 ms; repetition rate 1–2 s−1) and 500 MHz Clean-TOCSY spectra (to suppress ROESY response [52]; 25°, 35°C, spin lock 25 ms; repetition rate 1–2 s−1) were recorded over a bandwidth of 25 KHz (NOESY) and 12 KHz (TOCSY) using 512 t1 blocks of 128 and 256 scans each consisting of 2048 t2 points. 2D data sets were processed using Bruker XWIN software on a Silicon Graphics Indigo workstation. The processing consisted of 30°- or 45°-sine-squared-bell-apodization in both dimensions, and zero-filling to 2048 × 2048 data points prior Fourier transformation.

2.3. Magnetic axes determination

The anisotropy and orientation of χ were determined [20,23,39,47,48] by finding the Euler rotation angles, Γ(α,β,γ), that rotate the crystal structure based, iron-centered reference coordinate system, x′, y′, z′, into the magnetic coordinate system, x, y, z, where the paramagnetic susceptibility tensor, χ, is diagonal; α, β and γ are the three Euler angles where β corresponds to the tilt of the major magnetic axis, z, from the heme normal z′, α reflects the direction of this tilt, and is defined as the angle between the projection of the z axis on the heme plane and the x′ axis (Fig. 1), and κ = α + γ is the angle between the projection of the x, y axes onto the heme plane and locates the rhombic axes. A least-square search was carried out for the minimum in the error function [39,47,48], F/n

F/ni=1n|δdip(obs)δdip(calc)|2, (2)

with observed dipolar shift, δdip(obs) given by

δdip(obs)=δDSS(obs)δDSS(dia), (3)

where δDSS(obs) and δDSS(dia) are the chemical shifts, in ppm, referenced to DSS, for the paramagnetic NmHO–PH–N3 complex and an isostructural diamagnetic complex, respectively. In the absence of an experimental δDSS(dia) for the latter, it may be reasonably estimated by the ShiftX program [53] based on molecular structure, [19] as described previously for NmHO–PH–CN [20,21,24] and NmHO–PH–H2O [21,23]. Error analyses were performed with Levenberg–Marguard method, [54,55] as described previously [56]. The ShiftX program has been shown [53] to provide reliable estimates to within one- or two-tenth of a ppm with random deviations. Since numerous protons for NmHO–PH–N3 exhibit |δdip| in the range 2–3 ppm, the potential error in δdip(obs) becomes negligible. An uncertainty of ~0.1 ppm for δdip(calc) dictates that only differences in chemical shifts between two complexes greater than 0.2 ppm can be considered significant.

3. Results

3.1. Comparison of azide and cyanide complexes

The resolved portions of the 600 MHz 1H NMR spectrum of native NmHO–PH–N3 in 1H2O (Fig. 2A); and 2H2O (Fig. 2B) reveal the assigned [25] three low-field heme methyl peaks in the 18–22 ppm window, and a strongly shifted and strongly relaxed labile proton signal at 32 ppm, as well as two methyls and several single protons in the upfield spectral window. Protohemin peaks are labeled by the Fischer notation and residue peaks by residue number for peptide NHs, and both residue number and position for other proton signals. The minor methyl peaks in the 19–21 ppm window, labeled with asterisks (in Fig. 2A and B), arise from a minor species. The resolved heme methyls of native NmHO–PH–N3 exhibit nonselective T1s of ~40 ms, and the upfield vinyl Hβ display T1 ~ 60 and 80 ms, while the upfield peaks labeled 26γ1 and 119β1 exhibit T1s ~ 50 and ~40 ms. The low-field labile proton peak labeled 121 exhibits a T1 ~ 30 ms. The same spectral regions of NmHO–PH–CN in 1H2O, with the reported assignments, [20] are reproduced in Fig. 2A′. The temperature dependence for the azide complex (not shown; see Supporting Information) reveals weak anti-Curie behavior for the PH methyls and His23 NδH and Curie behavior for other protons.

Fig. 2.

Fig. 2

Resolved portions of the 600 MHz 1H NMR spectra of WT (species A) NmHO–PH–N3, 50 mM phosphate, pH 7.1 at 25 °C in: (A) 1H2O and (B) 2H2O; the same portions of the spectrum for the previously characterized NmHO–PH–CN complex [20] are shown in (A′). Heme peaks are labeled in the Fischer notation and peaks from active site residues assigned by 2D NMR are labeled by residue number and position, and only by resonance number for peptide NHs.

3.2. Cross-saturation between NmHO–PH–H2O and NmHO–PH–N3

Fig. 3 illustrates the heme methyl spectral window for the high-spin [21] NmHO–PH–H2O (Fig. 3A and B) and NmHO–PH–N3 complexes (Fig. 3A′ and B′) for an equilibrium mixture of NmHO–PH–H2O/NmHO–PH–N3 shortly after preparation (Fig. 3A and A′) and ~24 h later (Fig. 3B and B′). The NmHO–PH–H2O methyl peaks in Fig. 3A and B illustrate the spontaneous conversion of the WT (designated A; Ser2-His209, peak iCH3A ) NmHOA–PH–H2O, to the cleaved [22] (designated X; Ser2-Arg207, peak iCH3x), NmHOX–PH–H2O, complexes ( Fig. 3A and B), as detailed previously [20,22]. Only the 8CH3A , 8CH3X chemical shifts can be distinguished [22] in the high-spin complex. The conversion of A→X for the aquo complexes (Fig. 3A and B), is also observed for the azide complex (Fig. 3A′ and B′).

Fig. 3.

Fig. 3

The heme methyl spectral window for the high-spin NmHO–PH–H2O complexes (with methyl peak labeled iCH3A for the initial, native complex and iCH3X for the “aged” or cleaved complex, as described previously [22]) at two different times (A, B), and for the low-spin NmHO–PH–N3 complex (methyl peak iCH3A for the initial, native complex and iCH3X for the “aged” complex) at the same two times (A′, B′), both at 25 °C, 50 mM phosphate and pH 7.1. (C–G) correspond to the sequential saturation of peaks 8CH3X,8CH3A,(5CH3A,5CH3X),(1CH3A,1CH3X)and(3CH3A,3CH3X)of the NmHO–PH–H2O complexes as indicated by vertical arrows; and (C′–G′) correspond to the difference spectra for these same resonances in the NmHO–PH–N3 complexes, respectively.

The panels C–G of Fig. 3 illustrate the magnetization-transfer [41] observed for the azide complex (Fig. 3C′–G′), as the assigned methyls [21] of the aquo complex (Fig. 3C–G) are saturated, as indicated by vertical arrows. Saturating the 8CH3A peak of NmHOA–PH–H2O confirms the previously reported [25] 8CH3A peak of NmHOA–PH–N3 (Fig. 3D and D′) and saturation of 8CH3X of NmHOX–PH–H2O identifies 8CH3X for NmHOX–PH–N3. Similarly, saturation of the A/X pairwise degenerate 5CH3A/5CH3X, 1CH3A/1CH3X and 3CH3A/3CH3X peaks (Fig. 3E–G), respectively, leads to cross-saturation to the previously assigned [25] iCH3A for i = 1, 3, 5 of the NmHOA–PH–N3/NmHO–PH–N3, which confirms the methyl assignment for the WT–A complex [25] and locates the same iCH3x peak for NmHOX–PH–N3 (Fig. 3E′–G′, respectively). The magnitude of the cross-saturation in a steady-state difference spectrum for NmHO–PH–H2O/NmHO–PH–N3 is very similar to that observed in the pair metMbH2O/metMbN3 [43]. The majority of the remaining 2D NMR characterization was carried out on the uncleaved, native NmHO–PH–N3 complex. The absence of a superscript hereafter designates the “A” or WT complex. The chemical shift for the assigned protohemin peaks are very similar to that reported previously [25] and is listed in Supplementary material (Table S1).

3.3. Residue assignment protocols

The assignment protocols for the NmHO–PH–N3 complex are the same as those previously successfully [20,24] employed for the NmHO–PH–CN complex; sequential assignments by the helical NiNi + 1, αi-Ni + 1, βi-Ni + 1, αi-Ni + 3 and/or αi–βi+3, NOESY connections among TOCSY-identified spin systems [57], when allowed by resolution and relaxation. Since relaxation is ~5-fold faster in N3 than CN complexes, [20] paramagnetic relaxation (T1R−6) and NOESY data are used to support assignments when line broadening obliterates TOCSY cross-peaks. Extensive use is made of 2D data at several temperatures to establish the uniqueness of cross-peaks. The assignments are greatly facilitated by the fact that the pattern of dipolar-shifted, non-ligated amino acid residue resonances in NmHO–PH–N3 is very similar to that for the NmHO–PH–CN complex [20]. This is obvious even in the reference spectra (Fig. 2), as shown for the low-field Ala121 NH and the upfield Ala26 and Leu119 methyls shifts. Hence, we illustrate 2D data only for assigning the key proximal helix residues in NmHO–PH–N3 necessary to determine the magnetic axes and to identify key heme contact residues. Other 2D data are provided in Supplementary material (Table S2).

3.4. The proximal helix

Sequential α-helical contacts (illustrated in Fig. 4) among TOCSY-detected residues (not shown; see Supplementary material; Figs. S1 and S2) locate the fragment: AMXi-Thri + 1-Thri + 2-Alai + 3-Vali + 4-Ni + 5-AMXi + 6-Ni + 7-Vali + 8, which must arise from the proximal helix residues Asp18-Val26. The key axial His23 CαH–CβH2 fragment is too strongly relaxed to exhibit TOCSY cross-peaks (or NOESY cross-peaks in Fig. 4) to Ni + 5, but the characteristic NOESY intra-residue cross-peaks among the strongly relaxed and strongly low-field shifted protons are readily observed under more rapid pulsing conditions (not shown; see Supplementary material; Fig. S3). NOESY connections of residues with PH are shown in Fig. 5. The obvious Val26 with its expected methyl NOESY cross to the 3CH3 (Fig. 5D) and 4Hβs (Fig. 5E) exhibits TOCSY connections for only a CαH–CβH–CγH3 fragment, but the expected, and observed, resolved and relaxed (T1 ~ 50 ms) Cγ2H3 peak exhibits the expected intra- and inter-residue NOESY cross-peak. The very strongly relaxed (<20 ms at low temperature) labile proton at 32 ppm exhibits significant saturation-transfer above 20 °C, and displays no NOESY cross-peaks. Both the relaxation and saturation-transfer are those expected for the His23 ring NδH, as confirmed directly [20] in NmHO–PH–CN. The chemical shifts for the proximal helix residues for NmHO–PH–N3 are listed in Table 1, where they can be compared to those previously reported for the NmHO–PH–CN complex; [20] the similarity in both the pattern of shift and the shift magnitudes is striking.

Fig. 4.

Fig. 4

Portions of the 600 MHz 1H NMR NOESY spectrum of NmHO–PH–N3 in 1H2O, 50 mM in phosphate, pH 7.1 at 25 °C, illustrating the α-helical (A, B) Ni − Ni + 1, (arrows) and some αi-Ni + 1 (C, D) contacts for the hyperfine shifted residues Asp18-Val26, of the proximal helix and the Ni − Ni + 1 contacts for the hyperfine shifted portion of Ala114-Gly116 of the distal helix (B). Residues are labeled as described in Fig. 3 and Fig 4.

Fig. 5.

Fig. 5

Portions of the 600 MHz 1H NMR NOESY spectrum (mixing time 40 ms, repetition rate 2 s−1) of NmHO–PH–N3 in 1H2O, 50 mM in phosphate, pH 7.1 at 25 °C, illustrating the key heme contacts and interactions among such paramagnetically influenced active site residues, (A) 8CH3; (B) 1CH3 and 5CH3; (C) 6Hα and 7Hα; (D) 3CH3 as well as key intra-residue contacts, and (D) 4Hβs. The peak marked 208α and 207β in (A) are abolished in the “aged” or cleaved complex.

Table 1.

Chemical shift data for assigned residues in NmHO–PH–Xa

X=N3
X = CN Shift differences


δDSS(obs)b δdip(calc)c δDSS(obs)d ΔδDSS(obs)e Δδdip(calc)f
Ala12 NH 9.04 −0.16 8.96 0.08 0.05
CαH 3.38 −0.26 3.30 0.08 0.06
CβH3 1.17 −0.29 1.02 0.15 0.11
Leu15 CγH 0.54 −0.12 0.57 −0.03 −0.03
Cδ1H3 −0.65 −0.28 −0.65 0.00 −0.03
Cδ2H3 0.11 −0.14 0.21 −0.10 −0.10
Asp18 NH 8.60 0.34 8.64 −0.04 −0.02
CαH 4.91 0.43 4.97 −0.06 −0.05
Cβ1H 2.87 0.29 2.95 −0.08 −0.09
Cβ2H 2.78 0.26 2.85 −0.07 −0.03
Thr19 NH 7.98 0.75 8.04 −0.06 −0.10
CαH 5.28 0.93 5.52 −0.24 −0.20
CβH 5.23 1.03 5.75 −0.52 −0.50
CγH3 1.41 0.43 1.70 −0.29 −0.20
OηH 5.60 0.36 5.90 −0.28 −0.30
Thr20 NH 8.38 1.30 8.37 0.01 −0.09
CαH 6.38 3.45 6.30 0.08 −0.15
CβH 5.25 1.37 5.14 0.11 0.01
CγH3 2.41 2.11 2.27 0.14 0.10
Ala21 NH 9.27 1.36 9.36 −0.09 −0.12
CαH 5.23 1.43 5.31 −0.08 −0.11
CβH3 1.97 0.89 2.04 −0.07 −0.09
Val22 NH 9.14 1.40 9.44 −0.30 −0.24
CαH 4.60 1.11 4.87 −0.27 −0.21
CβH 2.44 0.79 2.72 −0.28 −0.23
Cγ1H3 1.04 1.15 1.56 −0.52 −0.44
Cγ2H3 1.17 0.60 1.40 −0.23 −0.20
His23 NH 10.54 3.10 11.08 −0.54 −0.57
CαH 6.25 4.82 7.37 −1.12 −1.38
Cβ1H 12.50 11.53 g
Cβ2H 9.54 10.75 g
Asp24 NH 11.07 4.13 11.41 −0.34 −0.27
CαH 6.44 3.65 6.80 −0.36 −0.20
Cβ1H 3.52 1.59 3.65 −0.13 −0.10
Cβ2H 4.14 2.02 4.30 −0.16 −0.13
Ser25 NH 8.60 1.85 8.77 −0.17 −0.17
Val26 NH 8.28 1.42 8.33 −0.05 −0.08
CαH 3.12 −0.27 2.80 0.32 0.27
CβH 1.57 0.64 1.60 −0.03 0.05
Cγ1H3 −0.98 −2.41 −1.96 0.98 0.94
Cγ2H3 0.43 −0.09 0.51 −0.08 −0.13
a

In 1H2O 50 mM in phosphate, pH 7.1 at 25 °C.

b

Chemical shifts, in ppm, referenced to DSS via the solvent resonance.

c

Dipolar shift, in ppm, at 25 °C for NmHO–PH–N3, calculated by the optimized orientation and anisotropies of the paramagnetic susceptibility tensor as described in Fig. 6.

d

Chemical shift, in ppm, referenced to DSS, as reported previously [20].

e

ΔδDSS(obs), as described in Eq. (5).

f

Δδdip(calc), as described in Eq. (4).

g

Possesses large contribution from contact shifts.

3.5. The distal helix

A three-residue helical fragment Phei-Xi + 1-Phei + 2 are observed (not shown) which is unique to Phe123-Leu124-Phe125 of the distal helix. The distal helix is sufficiently close to the iron that the factor ~4–5 increased relaxation rate in the azide compared to the cyanide complex [20] obliterates many TOCSY connections and interferes with even the NOESY detection of many Ni + Ni + 1 contacts. The remainder of the distal helix is approached via multiple characteristic contacts to protohemin in the crystal structure [19] and NmHO–PH–CN solution structure [20]. The contacts to substrate are illustrated in Fig. 5, with cross-peaks for 8CH3 (Fig. 5A) and 1CH3 (Fig. 5B) to Phe123 CβHs and ring (not shown), 5CH3 to Cys113 (CαH; Fig. 5B), Gly116 (NH, CαH; Fig. 5B), Trp153 ring (Fig. 5B), and Tyr112 ring (not shown), and 7Hα to Leu119 CδH3 (Fig. 5C). The identified Gly116 NH leads to both Glu115 and Ala114 via Ni + Ni + 1 contacts (Fig. 4B). The TOCSY-detected CH(CH3)2 fragment in contact with the propionates Hβs (not shown) can only arise from Leu119. A pair of strongly relaxed, up-field shifted geminal protons with NOESY contact to both the Leu119 CγH(CδH3)2 and a CαH, identify the Leu119 CβHs, with the T1 ~ 40 ms of the upfield peak consistent with an iron distance a little smaller than for a PH methyl. The expected sequential Ni − Ni + 1 connection for Ala114-Gly116 are illustrated in Fig. 4B. The strongly (Gly120) and moderately (Ala122) relaxed residues detected [20] in NmHO–PH–CN could not be located; neither NH is predicted (not shown; see Supplementary material; Table S2) to be resolved in the azide complex. However, a strongly relaxed (T1 ~ 30 ms; iron distance slightly shorter than for a PH methyl), low-field NH, exhibits the same pattern of NOESY cross-peaks [20] (and with approximately the same chemical shift), as Ala121 in NmHO–PH–CN, and is so assigned. The 20 ms T1 for the NH is consistent with iron distance slightly smaller than for heme methyl. The Phe45 ring makes the expected contacts to Val26 and Leu48 methyls (not shown; summarized in Fig. 1. The rings of Phe181 and Tyr184 were assigned based on the characteristic NOESY of a peak to 4Hβs (Fig. 5E), 3CH3 and 4Hβ (Fig. 5D and E). The pattern of observed (and expected) substrate contacts and inter-residue contacts are summarized in Fig. 1. The chemical shifts for distal helix residues are provided in Supplementary material (Table S2).

3.6. The distal H-bond network

Sequential Ni − Ni + 1 connections locate the fragment Gly138-Ala143 (not shown; see Supplementary material (Fig. S4), with the same inter-residue connections observed in NmHO–PH–CN, [20] with the peptide NHs of Arg140 and His141 exhibiting very strong low-field bias. Replacing 1H2O by 2H2O leads to exchange for many peptide NHs. However, numerous α-helical sequences (Ni − Ni + 1) are clearly observed, even a month after solvent exchange, and the improved resolution allows the confirmation of the Ala114-Gly116 backbone connectivities, together with Ala114 contact to Phe52 and Glu115, and Glu115 contact with Trp153 (see Supplementary material; Fig. S5). Two other helical fragments are detected in 2H2O (not resolved in 1H2O), comprise Phe52-His53, and Ala180-Val187 (not shown; see Supplementary material; Fig. S5). The retention of the Ni − Ni + 1 cross-peaks attest to remarkable slow exchange rates, as observed previously in NmHO–PH–H2O and NmHO–PH–OH complexes [21,23]. The chemical shifts for these residues are listed in Supplementary material (Table S2), where they are compared to the data [20] for NmHO–PH–CN.

3.7. The C-terminus

Crystal structures predict [18,19] only Gly120 CαH (too strongly relaxed to be detected) and Phe123 CβHs NOESY cross-peaks to 8CH3 (observed; [20] Fig. 5A). The contacts to the 8CH3 which are inconsistent with the crystal structures [7,8] are by the CβHs (Fig. 5A) of a CαHCβH2 spin system that also makes contact to a narrow non-labile proton diagnostic of a His CδH, and to a CαH (Fig. 5A) of another residue in a fashion very similar to that reported for NmHO–PH–CN [20,24]. The residues are similarly assigned to His207 and Arg208; chemical shifts are included in Supplementary material (Table S2). Qualitative modeling for NmHO–PH–CN has indicated that the His207 peptide NH forms a H-bond with the carboxylate of Asp27 and the Arg208 guanidyl group makes a salt bridge with the 7-propionate. [22] Each of the His207/Arg208 NOESY cross-peaks moves upfield at lower temperatures (not shown), indicative of sizable upfield δdip. The observation of similar cross-peaks to 8CH3 in the azide and cyanide complexes dictates that the C-terminus interacts similarly with the substrate pocket in the two complexes. Consistent with this conclusion, the conversion of NmHO–PH–N3 from the native (A) to the cleaved (X) form, we observe (not shown) the loss of all His207 and Arg208 cross-peaks to the 8CH3.

3.8. Determination of the magnetic axes

The anisotropies and orientation of χ obtained from a five-parameter fit of δdip(obs) via Eqs. (1)(3), using only non-labile proximal helix proton δdip as input, with geometric factors drawn from the NmHO–PH–NO crystal structure [19], are: Δχax = 2.3 ± 0.1 × 10−8 m3/mol; Δχrh = −0.1 ± 0.1 × 10−8 m3/mol, α = 240 ± 20°, β = 5 ± 1° and κ ~ α + γ = 140 ± 30°. The correlation between δdip(obs) and δdip(calc) for the optimized magnetic axes (closed markers) is excellent, as illustrated in Fig. 6. When δdip(obs) is plotted versus δdip(calc) for non-labile protons of residues not utilized in determining the magnetic axes (open markers in Fig. 6), a very good correlation is observed for all but the distal helix Ala121 residue. Leu119 has variable orientations in both crystals [18,19] and solution [20] and hence is not included. The reported [20] relevant parameters for NmHO–PH–CN are Δχax = 2.5 ± 0.1 × 10−8 m3/mol, Δχrh = −0.6 ± 0.1 × 10−8 m3/mol, α = 257 ± 10°, β = 10 ± 1° and κ ~ α + γ = 38 ± 10° [20].

Fig. 6.

Fig. 6

Plot of δdip(obs) versus δdip(calc) for the optimized anisotropy and orientation of χ for NmHO–PH–N3, with Δχax = 2.3 ± 0.1 × 10−8 m3/mol, Δχrh = −0.1 ± 0.1 × 10−8 m3/mol, α = 240 ± 20°, β = 5 ± 1° and κ = 140 ± 30°. The input data (proximal helix only) are shown in closed circles, the other, non-input data for the distal helix (open squares), the loop His137-Leu142 (open circles), and the helical fragment Ala180-Val187 (open diamonds). Points that deviate significantly from the ideal fit, which is represented by the solid line of unit slope, are labeled by residue number and position.

A large number of residues spread well over the enzyme exhibit significant δdip, as illustrated in a graph of δdip(calc) for peptide NHs as a function of sequence number as shown in Fig. 7A. The magnitude and distribution of δdip(calc) for the peptide NHs for the previously reported magnetic axes for NmHO–PH–CN are also large and distributed similarly, but not identically, as illustrated in Fig. 7B. Thus, residues with |δdip| ≥ 0.2 ppm at 20 Åare common for both the azide and cyanide complexes, so that δdip for each of the complexes must be considered to resolve any differences in molecular structure/H-bonding from differences in chromophore electronic/magnetic properties between the two complexes.

Fig. 7.

Fig. 7

Plot of chemical shift data, in ppm, for peptide NHs versus residue number for NmHO–PH–N3 and NmHO–PH–CN in 1H2O, 50 mM phosphate, pH 7.0 and 25 °C; (A) δdip(calc; NmHO–PH–N3), as determined in Fig. 6; (B) δdip(calc: NmHO–PH–CN) as reported previously, [20] (C) Δδdip(calc) = δdip(calc: NmHO–PH–N3) − δdip(calc: NmHO–PH–CN); Eq. (4) for data shown in A and B, respectively; (D) ΔδDSS(obs) = δDSS(obs:NmHO–PH–N3) − δDSS(obs:NmHO–PH–CN); Eq. (5), for assigned peptide NHs.

4. Discussion

4.1. Magnetic properties and electronic structure

The anisotropies and orientation of χ have been previously reported for NmHO–PH–CN [20] and determined herein for NmHO–PH–N3. The Δχax values are very similar, with that for the azide complex some 10% smaller than for the cyanide complex. The Δχrh is significantly smaller, and exhibits larger uncertainty, for the azide than cyanide complex. The tilt of the major magnetic (z-) axis is correlated [9,20,39] with the tilt of the Fe–N/C vector from the heme normal, is smaller in the azide than cyanide complex since the azide Fe–N3 is bent (while the FeCN unit is linear) and experiences less steric tilting by the distal helix backbone. The Fe–N tilt in the azide complex is similar to that observed in the azide complex of rat HO [13]. In each case the tilt (−z direction) is towards the α-meso position that is cleaved. The magnetic properties are surprisingly similar in the azide and cyanide complexes in view of the proposed differences [25] in the spin state for the cyanide (S = 1/2) and azide (S = 3/2) complexes. This similarity in Δχax values, however, does not preclude a difference in the spin state for the two ligands.

4.2. Comparison of molecular structure in the azide and cyanide complexes

The pattern of NOESY cross-peaks between the heme and contact residues and among residues in the presently studied azide complex, are very similar to those reported [20,22] for the NmHO–PH–CN, which, in turn, were consistent with the NmHO–PH prediction of the crystal structure [19], with the important exception of the 8CH3 contacts of the His207Arg208 C-terminus (see below)and the 180° rotation of the Gln49 and His53 side chain termini relative to those found in the crystal structures [18,19]. The NOESY contacts that differentiate the alternate orientation for Gln49 and His53 have been considered in detail previously [20,22,24], and have been documented in all solution NMR studies.

Comparison of data for the azide and cyanide complexes of NmHO–PH (Table 1; also see Supplementary material; Table S2) reveals that the chemical shifts for both non-labile and labile protons a large fraction of the residues differ significantly, even for some residues as far as 20 Å from the heme. The question that arises whether the widespread chemical shift differences between CN and N3 complexes of NmHO–PH are due to primarily differences molecular structure/H-bonding or mainly different orientations/ anisotropies of χ (i.e., electronic structural properties of the chromophore)? The plot of δdip(calc) versus sequence number for the peptide NHs of NmHO–PH–N3 (Fig. 7A) and NmHO–PH–CN (Fig. 7B) reveal large δdip with similar but not identical distribution about the enzyme manifold. Light is shed on this question by considering the differences in both the calculated dipolar shifts and observed shifts between the cyanide and azide complexes. Hence, we define the difference in the calculated dipolar shifts between the azide and cyanide complexes, Δχdip(calc), as

Δδdip(calc)=δdip(calc:NmHOPHN3)δdip(calc:NmHOPHCH), (4)

and the difference in the observed shifts between the azide and cyanide complexes, ΔχDSS(obs), as

ΔδDSS(obs)=δDSS(obs:NmHOPHN3)δDSS(obs:NmHOPhCN), (5)

of which the latter is equal to Δχdip(obs) in the absence of differences in molecular structure or H-bond strength.

We consider first the non-labile protons whose chemical shift differences could, in principle, reflect on molecular structural differences between the two complexes. The correlation between Δχdip(calc), (Eq. (4)), versus ΔχDSS(obs), (Eq. (5)), for all assigned, non-labile protons for the two complexes, except Leu119 which exhibits variable orientations in both crystals [18,19] and solution, [20] is very good, as shown in Fig. 8, although there are some deviations in the magnitude of the difference for Ala121. However, this portion of the distal helix residue is very close to the exogenous ligand, and small, local structural accommodation of the distal helix not unexpected. Hence we conclude that the wide variation in chemical shift differences for non-labile protons between the azide and cyanide complex can be interpreted primarily on the basis of variable dipolar shifts, and that these shift differences provide no direct evidence for detectable molecular structural accommodation upon substituting N3 for CN as ligand in NmHO, but do suggest some minor local structural accommodation of the distal helix near the exogenous ligand binding site.

Fig. 8.

Fig. 8

Plot of ΔδDSS(obs) (δDSS(obs; NmHO–PH–N3) − δDSS(obs; NmHO–PH–CN)); Eq. (4)) versus Δδdip(calc) (δdip(calc; NmHO–PH–N3) − δdip(calc; NmHO–PH–CN)); Eq. (5)), for non-labile protons of non-ligated residues, with δdip(calc) obtained for the optimized magnetism for NmHO–PH–N3 (described in Fig. 6) and for NmHO–PH–CN, as reported [20] previously. Data, are shown for the proximal helix (open circles), distal helix (open squares), fragment His137-Leu142 (closed circles), fragment Ala180-Val187 (open diamonds). Side chain labile protons are also included as x. Points that deviate significantly from the ideal fit, which is represented by a solid line of unit slope, are labeled by residue number and positions.

4.3. Comparison of H-bonding in azide and cyanide complexes

The patterns of the peptide NH δdip(calc) with NmHO residue number for NmHO–PH–N3 and NmHO–PH–CN are plotted in Fig. 7A and B, respectively. Comparison of Fig. 7A and B reveals a very similar (but not identical) pattern of nodes (change in the sign of δdip(calc)) and similar magnitudes for δdip(calc). The differences between the two complexes are emphasized in Fig. 7C, where we plot Δχdip(calc) (with ×8 vertical expansion relative to Fig. 7A and B) for the peptide NHs of the two complexes as given by Eq. (4), as a function of residue number. Fig. 7D provides the same plot of difference in observed peptide NH shifts between the azide and cyanide complexes, ΔχDSS(obs) (Eq (5)), which, in the absence of differences in H-bonding and molecular structure between the two complexes, should reflect the difference in δdip(obs). The very good correlation in both pattern and magnitude of the predicted difference in dipolar shifts and difference in observed shift argues strongly that, by far the primary source of the observed peptide NH chemical shift differences in the two complexes is the difference in the electronic structure, and not molecular structure and/or not H-bonding, between the N3 and CN complexes. The uncertainties in δdip(calc) for each complex preclude attributing any significance to chemical shift differences of less than ~0.2 ppm.

This conserved backbone NH H-bond strengths are consistent with the conclusion that molecular structure, as reflected in chemical shift for non-labile protons, differs inconsequentially between the azide and cyanide complex, except for the distal helix in the vicinity of the exogenous ligand. However, some local distortion of the distal helix portion near the exogenous ligand can be expected, and also observed for non-labile protons (Fig. 8).

The plot of Δδdip(calc) versus ΔδDSS(obs) for side chain labile protons is included in Fig. 8 (crosses). Again, essentially all observed differences are accounted for by the predicted differences in δdip(calc), with the exception of the Gln49 NεH. The deviations in Fig. 8 corresponds to low-field bias for the N3 relative to the CN complex, reflecting a somewhat stronger Gln49 NεH H-bonding in the former than the latter complex. The His53 NεH exhibits a 0.13 ppm lower-field bias in the azide than cyanide complexes as predicted by Δδdip(calc). While this might suggest a slightly stronger H-bond in the azide complex, the difference is well under the 0.2 ppm uncertainty and may not be significant. The crystal structure of NmHO–PH–NO shows[19] that Gln49 (rotated by 180°, as documented by solution NOESY cross-peaks [20,24]), is linked to the exogenous iron ligand by two ordered water molecules (#243 and #37), while His53 is linked to the same iron ligand by three water molecules (#77, #243 and #37). The low-field bias of the Gln49 NH in the N3 relative to the CN complex is consistent with N3 serving as a slightly stronger H-bond acceptor than CN. The absence of any significant difference (>0.2 ppm) in the His53 NεH shift in the two complexes likely reflects the weaker coupling to the axial ligand because of an additional intervening water molecule. Thus the available data provide direct evidence for a detectable difference in H-bond strength for only one residue in the distal H-bonding network.

4.4. Relationship to other studies

Magnetic axes have not been reported for either the CN or N3 complexes of PaHO. However, PaHO and NmHO exhibit significant sequence and structural homology, [3,5,19,29,44] and backbone assignments have been reported for PaHO–PH–CN and PaHO– PH–N3 complexes [32]. Widespread small to moderate chemical shift differences between the two complexes were interpreted as reflecting small conformational differences within a conserved secondary structure. [32] We note that the reported [32] patterns of shift differences (Fig. 8b in Ref. [32]) with residue number for peptide NHs and carboxyl 13C=O in PaHO–PH–N3 and PaHO–PH–CN complexes are very similar to that reported here (Fig. 7C) for the peptide NHs for the same pair of NmHO–PH complexes. The more comprehensive backbone 3D NMR assignments of isotope-labeled PaHO in both the paramagnetic azide and cyanide complexes [32], and more recently, in the ferrous CO complex [58] that can serve as a diamagnetic reference, provide the data necessary to quantitate the magnetic anisotropies/orientations and resolve differences in molecular structure/H-bonding from differences in electronic structure in the azide and cyanide complexes of PaHO.

It has been reported that the dynamic stability, as evidenced by NH exchange [32] is significantly greater in the N3 than CN complexes of PaHO, and preliminary data indicate moderately slower NH exchanges in azide than cyanide complexes of NmHO. Such a difference in dynamic stability does not require any ground state molecular structural difference, only a shallower potential well for the CN complex [59]. Reduced dynamic stability of the CN complex can, in part, be rationalized by the strain induced in requiring a steric tilt of the Fe–CN unit [20], as also observed for the cyanide complex of rat HO [13].

4.5. Interaction of the C-terminus with the active site and cleavage Arg208His209

The initially prepared NmHO–PH–N3 complex exhibits essentially the same pattern of 8CH3 NOESY cross-peak as reported [20] for NmHO–PH–CN, both of which are inconsistent with the crystal structures, [18,19] but consistent with an interaction of His207 and Arg208 with the active site as previously modeled [22] for the cyanide complex, where the Arg sidechain makes a salt bridge with the 7-propionate carboxylate, and the His207 peptide NH makes a H-bond to the carboxylate sidechain of Asp27 (see Fig. 9 of Ref. [22]). This interaction brings the His207 CβHs and the Arg208 CαH close to the 8CH3, as observed (Fig. 5A). The “aging” of the azide complex leads to the loss of the His207 and Arg208 8CH3 contacts. The heme methyl resonances for the cleaved NmHO–PH–N3 complex have been observed in other NMR studies, [25] and the facile cleavage emphasizes the need to follow NmHO studies by either NMR or mass spectrometry [24] to establish the integrity of the native NmHO. Lastly, the electronic structure of the azide complex provides resolved substrate 1CH3 and 8CH3 signals for which it is much easier to detect and characterize the C-terminal interaction with the active site than in the cyanide complex, where the key heme methyl peaks are only partially resolved even in 2H2O solution. Further studies of the C-terminal interaction with substrates in azide complexes are in progress.

5. Conclusions

Several conclusions are indicated. (1) Saturation-transfer between the difficult-to-assign, strongly relaxed heme methyls of high-spin HO–PH–H2O, and the more readily assigned heme methyls of much less severely relaxed HO–PH–N3, serves as a useful and effective route to identify the resonances in the physiologically relevant HO–PH–H2O complex without reliance on isotope labeling. (2) Quantitative consideration of the anisotropies and orientations of χ in the CN and N3 complexes of NmHO establishes that observed sizable and widespread chemical shift difference between the CN and N3 complex result primarily from the difference in the χ orientation/anisotropies. Therefore, no firm conclusions on differences in molecular structure and H-bond strengths for the two complexes can be drawn from the available NMR data; this conclusion may also apply to the same pair of PaHO complexes [32]. (3) The crystallographically undetected [18,19] C-terminus interacts with the active site and the two terminal residues are spontaneously cleaved in the azide complex in a manner very similar to that reported for the cyanide complex [22,24].

It is important to note that, while the observed chemical shift differences between the azide and cyanide complexes of NmHO–PH cannot be interpreted in terms of molecular structure/H-bond differences between the two complexes, this does not preclude the presence of some differences in molecular structure and H-bond strength. This is due to the fact that the differences in δdip(-calc) are so large as to mask most differences in structure/H-bonding.

Supplementary Material

pdf

Acknowledgments

This work was supported by Grants from the National Institutes of Health, GM62830 (GNL), and HL16087 (GNL), and a Grant-in-Aid for Scientific Research (16570102) from the Ministry of Education and Sports, Science and Teaching, Japan (T.Y.).

Abbreviations

HO

heme oxygenase

hHO

human heme oxygenase #1

NmHO

Neisseria meningitidis heme oxygenase

CdHO

Corynebacterium diphtheriae heme oxygenase

PaHO

Pseudomonas aeruginosa heme oxygenase

NOE

nuclear Overhauser effect

NOESY

two-dimensional nuclear Overhauser spectroscopy

TOCSY

two-dimensional total correlation spectroscopy

PH

protohemin

Appendix A. Supplementary material

Supplementary data associated with this article can be found, in the online version, at doi:10.1016/j.jinorgbio.2008.08.012.

References

  • 1.Tenhunen R, Marver HS, Schmid R. J. Biol. Chem. 1969;244:6388–6394. [PubMed] [Google Scholar]
  • 2.Yoshida T, Migita CT. J. Inorg. Biochem. 2000;82:33–41. doi: 10.1016/s0162-0134(00)00156-2. [DOI] [PubMed] [Google Scholar]
  • 3.Wilks A. Antioxid. Redox Sig. 2002;4:603–614. doi: 10.1089/15230860260220102. [DOI] [PubMed] [Google Scholar]
  • 4.Ortiz de Montellano PR, Auclair K. In: The Porphryin Handbook, Heme Oxygenase Structure and Mechanism vol. 12. Kadish KM, Smith KM, Guilard R, editors. San Diego, CA: Elsevier Science; 2003. pp. 175–202. [Google Scholar]
  • 5.Rivera M, Zeng Y. J. Inorg. Biochem. 2005;99:337–354. doi: 10.1016/j.jinorgbio.2004.09.016. [DOI] [PubMed] [Google Scholar]
  • 6.Unno M, Matsui T, Ikeda-Saito M. Nat. Prod. Rep. 2007;24:553–570. doi: 10.1039/b604180a. [DOI] [PubMed] [Google Scholar]
  • 7.Schuller DJ, Wilks A, Ortiz de Montellano PR, Poulos TL. Nat. Struct. Biol. 1999;6:860–867. doi: 10.1038/12319. [DOI] [PubMed] [Google Scholar]
  • 8.Lad L, Wang J, Li H, Friedman J, Bhaskar B, Ortiz de Montellano PR, Poulos TL. J. Mol. Biol. 2003;330:527–538. doi: 10.1016/s0022-2836(03)00578-3. [DOI] [PubMed] [Google Scholar]
  • 9.Li Y, Syvitski RT, Auclair K, Wilks A, Ortiz de Montellano PR, La Mar GN. J. Biol. Chem. 2002;277:33018–33031. doi: 10.1074/jbc.M204216200. [DOI] [PubMed] [Google Scholar]
  • 10.Li Y, Syvitski RT, Auclair K, Ortiz de Montellano PR, La Mar GN. J. Am. Chem. Soc. 2003;125:13392–13403. doi: 10.1021/ja036176t. [DOI] [PubMed] [Google Scholar]
  • 11.Syvitski RT, Li Y, Auclair K, Ortiz de Montellano PR, La Mar GN. J. Am. Chem. Soc. 2002;124:14296–14297. doi: 10.1021/ja028108x. [DOI] [PubMed] [Google Scholar]
  • 12.Ogura H, Evans JP, Ortiz de Montellano PR, La Mar GN. Biochemistry. 2008;47:421–430. doi: 10.1021/bi7017333. [DOI] [PubMed] [Google Scholar]
  • 13.Sugishima M, Sakamoto H, Higashimoto Y, Omata Y, Hayashi S, Noguchi M, Fukuyama K. J. Biol. Chem. 2002:45086–45090. doi: 10.1074/jbc.M207267200. [DOI] [PubMed] [Google Scholar]
  • 14.Sugishima M, Sakamoto H, Higashimoto Y, Noguchi M, Fukuyama K. J. Biol. Chem. 2003;278:32352–32358. doi: 10.1074/jbc.M303682200. [DOI] [PubMed] [Google Scholar]
  • 15.Sugishima M, Migita CT, Zhang X, Yoshida T, Fukuyama K. Eur. J. Biochem. 2004;271:4517–4525. doi: 10.1111/j.1432-1033.2004.04411.x. [DOI] [PubMed] [Google Scholar]
  • 16.Li Y, Syvitski RT, Auclair K, Ortiz de Montellano PR, La Mar GN. J. Biol. Chem. 2003;279:10195–10205. doi: 10.1074/jbc.M308379200. [DOI] [PubMed] [Google Scholar]
  • 17.Chu GC, Tomita T, Sönnichsen FD, Yoshida T, Ikeda-Saito M. J. Biol. Chem. 1999;274:24490–24496. doi: 10.1074/jbc.274.35.24490. [DOI] [PubMed] [Google Scholar]
  • 18.Schuller DJ, Zhu W, Stojiljkovic I, Wilks A, Poulos TL. Biochemistry. 2001;40:11552–11558. doi: 10.1021/bi0110239. [DOI] [PubMed] [Google Scholar]
  • 19.Friedman JM, Lad L, Deshmukh R, Li HY, Wilks A, Poulos TL. J. Biol. Chem. 2003;278:34654–34659. doi: 10.1074/jbc.M302985200. [DOI] [PubMed] [Google Scholar]
  • 20.Liu Y, Zhang X, Yoshida T, La Mar GN. Biochemistry. 2004;43:10112–10126. doi: 10.1021/bi049438s. [DOI] [PubMed] [Google Scholar]
  • 21.Liu Y, Zhang X, Yoshida T, La Mar GN. J. Am. Chem. Soc. 2005;127:6409–6422. doi: 10.1021/ja042339h. [DOI] [PubMed] [Google Scholar]
  • 22.Liu Y, Ma L-H, Satterlee JD, Zhang X, Yoshida T, La Mar GN. Biochemistry. 2006;45:3875–3886. doi: 10.1021/bi0523097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ma L-H, Liu Y, Zhang X, Yoshida T, La Mar GN. J. Am. Chem. Soc. 2006;128:6657–6668. doi: 10.1021/ja0584626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Liu Y, Ma L-H, Zhang X, Yoshida T, Satterlee JD, La Mar GN. Biochemistry. 2006;45:13875–13888. doi: 10.1021/bi061747q. [DOI] [PubMed] [Google Scholar]
  • 25.Zeng Y, Caignan GA, Bunce RA, Rodriguez JC, Wilks A, Rivera M. J. Am. Chem. Soc. 2005;127:9794–9807. doi: 10.1021/ja0425987. [DOI] [PubMed] [Google Scholar]
  • 26.Deshmukh R, Zeng Y, Furci LM, Huang H-w, Morgan BN, Sander S, Alontaga AY, Bunce RA, Moenne-Loccoz P, Rivera M, Wilks A. Biochemistry. 2005;44:13713–13723. doi: 10.1021/bi050810t. [DOI] [PubMed] [Google Scholar]
  • 27.Unno M, Matsui T, Chu GC, Coutoure M, Yoshida T, Rousseau DL, Olson JS, Ikeda-Saito M. J. Biol. Chem. 2004;279:21055–21061. doi: 10.1074/jbc.M400491200. [DOI] [PubMed] [Google Scholar]
  • 28.Zeng Y, Deshmukh R, Caignan GA, Bunce RA, Rivera M, Wilks A. Biochemistry. 2004;43:5222–5238. doi: 10.1021/bi035970o. [DOI] [PubMed] [Google Scholar]
  • 29.Friedman J, Lad L, Li H, Wilks A, Poulos TL. Biochemistry. 2004;43:5239–5245. doi: 10.1021/bi049687g. [DOI] [PubMed] [Google Scholar]
  • 30.Caignan GA, Deshmukh R, Wilks A, Zeng Y, Huang H-W, Moenne-Loccoz P, Bunce RA, Eastman MA, Rivera M. J. Am. Chem. Soc. 2002;124:14879–14892. doi: 10.1021/ja0274960. [DOI] [PubMed] [Google Scholar]
  • 31.Caignan GA, Deshmukh R, Zeng Y, Wilks A, Bunce RA, Rivera M. J. Am. Chem. Soc. 2003;125:11842–11852. doi: 10.1021/ja036147i. [DOI] [PubMed] [Google Scholar]
  • 32.Rodriguez JC, Wilks A, Rivera M. Biochemistry. 2006;45:4578–4592. doi: 10.1021/bi0600188. [DOI] [PubMed] [Google Scholar]
  • 33.Davydov RM, Yoshida T, Ikeda-Saito M, Hoffman BM. J. Am. Chem. Soc. 1999;121:10656–10657. [Google Scholar]
  • 34.Li Y, Syvitski RT, Chu GC, Ikeda-Saito M, La Mar GN. J. Biol. Chem. 2003;279:6651–6663. doi: 10.1074/jbc.M211249200. [DOI] [PubMed] [Google Scholar]
  • 35.Liu Y, Ma L-H, Zhang X, Yoshida T, Langry KC, Smith KM, La Mar GN. J. Am. Chem. Soc. 2006;128:6391–6399. doi: 10.1021/ja0578505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Koenigs Lightning L, Huang H-W, Moënne-Loccoz P, Loehr TM, Schuller DJ, Poulos TL, Ortiz de Montellano PR. J. Biol. Chem. 2001;276:10612–10619. doi: 10.1074/jbc.M010349200. [DOI] [PubMed] [Google Scholar]
  • 37.Fujii H, Zhang X, Tomita T, Ikeda-Saito M, Yoshida T. J. Am. Chem. Soc. 2001;123:6475–6484. doi: 10.1021/ja010490a. [DOI] [PubMed] [Google Scholar]
  • 38.Matsui T, Furukawa M, Unno M, Tomita T, Ikeda-Saito M. J. Biol. Chem. 2005;280:2981–2989. doi: 10.1074/jbc.M410263200. [DOI] [PubMed] [Google Scholar]
  • 39.La Mar GN, Satterlee JD, de Ropp JS. In: The Porphyrins Handbook, NMR of Hemoproteins, vol. 5. Kadish KM, Smith KM, Guilard R, editors. San Diego: Academic Press; 2000. pp. 185–298. [Google Scholar]
  • 40.Sugishima M, Sakamoto H, Noguchi M, Fukuyama K. Biochemistry. 2003;42:9898–9905. doi: 10.1021/bi027268i. [DOI] [PubMed] [Google Scholar]
  • 41.Sandström J. Dynamic NMR Spectroscopy. New York: Academic Press; 1982. [Google Scholar]
  • 42.Peyton DH. Biochem. Biophys. Res. Commun. 1991;175:515–519. doi: 10.1016/0006-291x(91)91594-3. [DOI] [PubMed] [Google Scholar]
  • 43.Yamamoto Y, Inoue Y, Suzuki T. Magn. Reson. Chem. 1993;31:S8–S16. [Google Scholar]
  • 44.Frankenberg-Dinkel N. Antoxidants Redox Signal. 2004;6:825–834. doi: 10.1089/ars.2004.6.825. [DOI] [PubMed] [Google Scholar]
  • 45.Zuiderweg ERP. Biochemistry. 2000;43:5222–5238. [Google Scholar]
  • 46.Bertini I, Luchinat C. Coord. Chem. Rev. 1996;150:1–296. [Google Scholar]
  • 47.Williams G, Clayden NJ, Moore GR, Williams RJP. J. Mol. Biol. 1985;183:447–460. doi: 10.1016/0022-2836(85)90013-0. [DOI] [PubMed] [Google Scholar]
  • 48.Emerson SD, La Mar GN. Biochemistry. 1990;29:1556–1566. doi: 10.1021/bi00458a029. [DOI] [PubMed] [Google Scholar]
  • 49.Johnston PD, Figueroa N, Redfield AG. Proc. Natl. Acad. Sci. USA. 1979;76:3130–3134. doi: 10.1073/pnas.76.7.3130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Piotto M, Sandek V, Sklenar V. J. Biomol. NMR. 1992;2:661–666. doi: 10.1007/BF02192855. [DOI] [PubMed] [Google Scholar]
  • 51.Jeener J, Meier BH, Bachmann P, Ernst RR. J. Chem. Phys. 1979;71:4546–4553. [Google Scholar]
  • 52.Griesinger C, Otting G, Wüthrich K, Ernst RR. J. Am. Chem. Soc. 1988;110:7870–7872. [Google Scholar]
  • 53.Neal S, Nip AM, Zhang H, Wishart DS. J. Biomol. NMR. 2003;26:215–240. doi: 10.1023/a:1023812930288. [DOI] [PubMed] [Google Scholar]
  • 54.Shrager RI. J. Assoc. Comput. Machin. 1970;17:446–452. [Google Scholar]
  • 55.Press WH, Flannery BP, Teukolsky SA, Vetterlin WT. Numerical Recipes. Cambridge: Cambridge University Press; 1986. [Google Scholar]
  • 56.Xia Z, Nguyen BD, Brunori M, Cutruzzola F, La Mar GN. Biophys. J. 2005;89:4149–4158. doi: 10.1529/biophysj.105.062398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Wüthrich K. NMR of Proteins and Nucleic Acids. New York: Wiley & Sons; 1986. [Google Scholar]
  • 58.Rodriguez JC, Zeng Y, Wilks A, Rivera M. J. Am. Chem. Soc. 2007:11730–11742. doi: 10.1021/ja072405q. [DOI] [PubMed] [Google Scholar]
  • 59.Englander SW, Kallenbach NR. Quart. Rev. Biophys. 1984;16:521–655. doi: 10.1017/s0033583500005217. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

pdf

RESOURCES